Pay in 4 interest-free payments of $6.42 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
[1] [2] According to the MHRA-approved product information, you may change your weekly injection day if necessary, provided at least 3 days (72 hours) have elapsed between doses
Retatrutide is a triple-agonist peptide targeting GLP-1 + GIP + glucagon receptors simultaneously the most pronounced weight-loss data from any metabolic peptide studied to date
[Hypermethioninemia in the differential diagnosis of infantile obstructive jaundice (authors transl)]
Pain and discomfort
The lack of patent protection (BPC-157 is a naturally-derived sequence) makes this investment unattractive commercially
US$ 26.34
US$ 25.99
US$ 24.28
US$ 22.31
US$ 25.56
US$ 28.63
US$ 23.95
US$ 25.86
